FineMark National Bank & Trust’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

FineMark National Bank & Trust’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-4	Closed	-$1K	–	1369
2015 Q4	$1K	Hold	4	–	–	﹤0.01%	1306
2015 Q3	$1K	Hold	4	–	–	﹤0.01%	1453
2015 Q2	$1K	Hold	4	–	–	﹤0.01%	1387
2015 Q1	$1K	Sell	4 -3	-43%	-$650	﹤0.01%	1364
2014 Q4	$1K	Buy	7 +4	+133%	+$739	﹤0.01%	1372
2014 Q3	$1K	Hold	3	–	–	﹤0.01%	1349
2014 Q2	$1K	Hold	3	–	–	﹤0.01%	1361
2014 Q1	$1K	Sell	3 -13	-81%	-$4.39K	﹤0.01%	1380
2013 Q4	$2K	Buy	+16	New	+$925	﹤0.01%	1333

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

FineMark National Bank & Trust's ICPT Position: Q1 2016 in Review

FineMark National Bank & Trust sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2016, closing a stake of 4 shares — an estimated $1K sold.

FineMark National Bank & Trust first reported a position in ICPT in Q4 2013 and held it in 9 quarters. The position peaked at $2K in Q4 2013. 160 funds tracked by Wall St. Rank hold ICPT as of Q1 2016.

FineMark National Bank & Trust reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
FineMark National Bank & Trust sold 4 Intercept Pharmaceuticals, Inc. shares in Q1 2016, an estimated $1K.
FineMark National Bank & Trust first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2013 and held it in 9 quarters.
FineMark National Bank & Trust's Intercept Pharmaceuticals, Inc. position peaked at $2K in Q4 2013.
160 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2016.

Based on FineMark National Bank & Trust's 13F filing for Q1 2016, filed 10 May 2016.